196 related articles for article (PubMed ID: 7008507)
1. Determination of optimum doses of insulin by the application of artificial pancreas in the treatment of diabetes.
Granić M
Acta Med Iugosl; 1980; 34(3):185-217. PubMed ID: 7008507
[No Abstract] [Full Text] [Related]
2. [Value of the determination of nyctohemerol blood glucose in the stabilization of insulin-dependent diabetes].
Lugand JJ; Dewailly P; Moulin S; Anaye B; Jaillard J
Lille Med; 1980 Nov; 25(9):490-5. PubMed ID: 7005586
[No Abstract] [Full Text] [Related]
3. Insulin resistant diabetes mellitus.
Zhu XX; Wang ZG; Qiu CL; Zhong XL
Chin Med J (Engl); 1980 Nov; 93(11):737-44. PubMed ID: 6775883
[No Abstract] [Full Text] [Related]
4. [Monitoring of blood sugar levels during insulin treatment of diabetes mellitus].
Chen JW
Zhonghua Yi Xue Za Zhi; 1984 Mar; 64(3):184-6. PubMed ID: 6432274
[No Abstract] [Full Text] [Related]
5. [Self-determination of blood glucose in insulin-dependent diabetes mellitus].
Andersen AR; Andersen JK; Svendsen PA; Frost-Larsen K; Christiansen JS; Deckert T
Ugeskr Laeger; 1980 Aug; 142(32):2038-42. PubMed ID: 6996263
[No Abstract] [Full Text] [Related]
6. [Fluctuation of blood glucose changes during the day. Study in diabetics with different insulin treatments].
Herrera Pombo JL; Arrieta F; Rodríguez-Miñón JL
Rev Clin Esp; 1978 Nov; 151(4):289-92. PubMed ID: 741008
[No Abstract] [Full Text] [Related]
7. [Intravenous insulin treatment of chronic insulin resistance].
Lohmann D; Janusch H; Bemm H; Rotzsch W; Kluge HO
Dtsch Z Verdau Stoffwechselkr; 1968; 28(5):337-44. PubMed ID: 5731588
[No Abstract] [Full Text] [Related]
8. [Results of diabetes treatment with delayed-action Silubin. 2].
Kopp H
Med Klin; 1967 Jun; 62(22):878-82. PubMed ID: 5594888
[No Abstract] [Full Text] [Related]
9. [Clinical application of open-loop systems for blood glucose control (author's transl)].
Granić M; Topić E; Stavljenić A; Skrabalo Z
Lijec Vjesn; 1980 Nov; 102(11):657-60. PubMed ID: 7024695
[No Abstract] [Full Text] [Related]
10. Home glucose monitoring for insulin-dependent diabetics: preliminary results.
Evans WS; Pohl SL
Va Med; 1980 Aug; 107(8):551-6. PubMed ID: 7010819
[TBL] [Abstract][Full Text] [Related]
11. [Improvement of diabetes mellitus in patients practicing self monitoring and management under outpatient supervision].
van Ballegooie E; Reitsma WD; Sluiter WJ; Doorenbos H
Ned Tijdschr Geneeskd; 1983 Jan; 127(2):44-50. PubMed ID: 6338403
[No Abstract] [Full Text] [Related]
12. [The correction of the glycemia level in patients with concomitant diabetes mellitus].
Khlystov VN; Kolesnik LA; Khlystov IV
Vestn Khir Im I I Grek; 1992 Apr; 148(4):105-7. PubMed ID: 1302909
[No Abstract] [Full Text] [Related]
13. [Differential effects of insulin on glycemia, NEFA and ketone bodies in diabetic subjects].
Odetti P; Viviani G; Diara C; Maiello M; Cordera R; De Micheli A; Peluffo F; Prando R
Clin Ter; 1980 Jul; 94(2):127-36. PubMed ID: 7004757
[No Abstract] [Full Text] [Related]
14. Clinical value of ketone body determinations in brittle diabetes.
Rooth G
Acta Med Scand; 1972 Jun; 191(6):549-57. PubMed ID: 5038228
[No Abstract] [Full Text] [Related]
15. [Use of the "Biostator" apparatus in patients with a labile course of diabetes mellitus].
Spesivtseva BG; Mamaeva GG; Seid-Guseĭnov AA; Turova EA; Leonova LN
Sov Med; 1983; (2):44-8. PubMed ID: 6344245
[No Abstract] [Full Text] [Related]
16. The artificial pancreas today.
McMurry JF
Henry Ford Hosp Med J; 1983; 31(2):77-83. PubMed ID: 6355015
[No Abstract] [Full Text] [Related]
17. [The implantable artificial pancreas for the treatment of diabetes mellitus].
Schumakow WI; Seid-Gusejnow AA
Z Arztl Fortbild (Jena); 1979 May; 73(10):490-2. PubMed ID: 556507
[No Abstract] [Full Text] [Related]
18. [Realization of the compensation principle and the regression of diabetic disorders in adults and children].
Kaiumov EG; Dmitrieva EN; Akbutaev MA
Vestn Akad Med Nauk SSSR; 1983; (2):48-52. PubMed ID: 6340365
[No Abstract] [Full Text] [Related]
19. Technological advances in the treatment of diabetes mellitus: better bioengineering begets benefits in glucose measurement, the artificial pancreas, and insulin delivery.
Klonoff DC
Pediatr Endocrinol Rev; 2003 Dec; 1(2):94-100. PubMed ID: 16437014
[TBL] [Abstract][Full Text] [Related]
20. [Use of an artificial beta-cell (Biostator) in clinical practice].
Andreev D; Arnaudov I; Veleva N; Todorova S
Vutr Boles; 1980; 19(6):60-6. PubMed ID: 6782760
[No Abstract] [Full Text] [Related]
[Next] [New Search]
